Fenwick & West LLP
Method for selecting anticancer agent based on protein damage information of individual to prevent anticancer agent side effects
The present invention relates to a method and a system for selecting an anticancer agent based on protein damage information of an individual by using individual genome sequencing. The method and the system, according to the present invention, are highly reliable and widely applicable techniques capable of predicting side effects or risks of specific drugs, in other words, anticancer agents, for each individual by performing sequence analysis of an exon part of a gene that codes various proteins involved in pharmacokinetics or pharmacodynamics of anticancer agents.
Cipherome, Inc.
G G G G G C C C
G16B G16B G16B G16B G16B C12Q C12Q C12Q
inventional inventional inventional inventional inventional additional additional inventional
Ju Han
Kim